Pharmaceuticals (648) | Bonus & Incentive Agreements (648)
Browse by Company
-
Acasti Pharma Inc. (1)
-
ACELRX PHARMACEUTICALS INC (6)
-
Acer Therapeutics Inc. (4)
-
Aclaris Therapeutics, Inc. (2)
-
Acreage Holdings, Inc. (2)
-
Adamis Pharmaceuticals Corp (3)
-
ADIAL PHARMACEUTICALS, INC. (1)
-
AERIE PHARMACEUTICALS INC (1)
-
Aerpio Pharmaceuticals, Inc. (4)
-
Akers Biosciences, Inc. (3)
-
ALIMERA SCIENCES INC (6)
-
Amag Pharmaceuticals (8)
-
Amneal Pharmaceuticals, Inc. (3)
-
Ampio Pharmaceuticals, Inc. (2)
-
Amylyx Pharmaceuticals, Inc. (3)
-
AN2 Therapeutics, Inc. (5)
-
Anebulo Pharmaceuticals, Inc. (1)
-
Angion Biomedica Corp. (8)
-
ANI Pharma Inc (3)
-
ARVINAS, INC. (2)
-
Assertio Holdings, Inc. (1)
-
Assertio Therapeutics, Inc (2)
-
ATAI Life Sciences B.V. (6)
-
Atea Pharmaceuticals, Inc. (4)
-
Athira Pharma, Inc. (8)
-
AVADEL PHARMACEUTICALS PLC (2)
-
Axsome Therapeutics, Inc. (2)
-
Bakhu Holdings, Corp. (1)
-
Baudax Bio, Inc. (2)
-
Bausch Health Companies Inc. (6)
-
Bespoke Extracts, Inc. (1)
-
BIODELIVERY SCIENCES INTERNATIONAL INC (5)
-
Biofrontera Inc. (4)
-
BioPharmX Corp (2)
-
Blue Water Acquisition Corp. (2)
-
Bristol-Myers Squibb (48)
-
Cannabics Pharmaceuticals Inc. (1)
-
Canopy Growth Corp (8)
-
CASSAVA SCIENCES INC (1)
-
Catalent Inc (7)
-
Cerecor Inc. (2)
-
CHINA PHARMA HOLDINGS, INC. (1)
-
CinCor Pharma, Inc. (1)
-
Cingulate Inc. (3)
-
Clever Leaves Holdings Inc. (5)
-
COGNITION THERAPEUTICS INC (6)
-
COLLEGIUM PHARMACEUTICAL, INC (1)
-
Columbia Care Inc. (1)
-
Context Therapeutics Inc. (3)
-
Corcept Therapeutics Incorporated (1)
-
CorMedix Inc. (3)
-
COSMO VENTURES INC (1)
-
Cronos Group Inc. (3)
-
CUMBERLAND PHARMACEUTICALS INC (2)
-
Cure Pharmaceutical Holding Corp. (4)
-
Cyteir Therapeutics, Inc. (9)
-
Dermata Therapeutics, Inc. (4)
-
DiCE MOLECULES HOLDINGS, LLC (2)
-
Edgewise Therapeutics, Inc. (3)
-
Elanco Animal Health Inc (7)
-
Endo International plc (13)
-
Eton Pharmaceuticals, Inc. (1)
-
Evofem Biosciences, Inc. (4)
-
Evolus, Inc. (1)
-
Exactus, Inc. (5)
-
EYEGATE PHARMACEUTICALS INC (1)
-
EYENOVIA, INC. (4)
-
EyePoint Pharmaceuticals, Inc. (3)
-
Fulcrum Therapeutics, Inc. (10)
-
GRAYBUG VISION, INC. (3)
-
Green Thumb Industries Inc. (2)
-
GW PHARMACEUTICALS PLC (2)
-
Harmony Biosciences Holdings, Inc. (5)
-
Horizon Pharma plc (6)
-
Ikena Oncology, Inc. (2)
-
IMARA Inc. (9)
-
INNOVATE BIOPHARMACEUTICALS, INC. (3)
-
Intersect ENT, Inc. (2)
-
Intra-Cellular Therapies, Inc. (5)
-
Jaguar Health, Inc. (1)
-
Jazz Pharmaceuticals plc (16)
-
Kala Pharmaceuticals, Inc. (3)
-
Kaleido Biosciences, Inc. (3)
-
Kannalife Inc (2)
-
KEMPHARM, INC (2)
-
Landos Biopharma, Inc. (1)
-
Lexaria Bioscience Corp. (1)
-
Lilly (Eli) & Co. (10)
-
Liquidia Corp (3)
-
Longboard Pharmaceuticals, Inc. (6)
-
Lyra Therapeutics, Inc. (5)
-
Mallinckrodt (2)
-
MARINUS PHARMACEUTICALS INC (10)
-
Medicine Man Technologies, Inc. (4)
-
MedMen Enterprises, Inc. (1)
-
Menlo Therapeutics Inc. (6)
-
Merck (4)
-
Milestone Pharmaceuticals Inc. (5)
-
Mind Medicine (MindMed) Inc. (2)
-
Mylan N.V. (5)
-
Nabriva Therapeutics plc (10)
-
NEKTAR THERAPEUTICS (3)
-
Neuralstem, Inc. (9)
-
NGM BIOPHARMACEUTICALS INC (3)
-
NovaBay Pharmaceuticals, Inc. (3)
-
Novan, Inc. (4)
-
OCULAR THERAPEUTIX, INC (4)
-
OMEROS CORP (2)
-
Onconova Therapeutics, Inc. (1)
-
One World Pharma, Inc. (3)
-
OPIANT PHARMACEUTICALS, INC. (2)
-
OptiNose, Inc. (1)
-
Organon & Co. (3)
-
Osmotica Pharmaceuticals plc (6)
-
Pacira Pharmaceuticals, Inc. (6)
-
Panacea Acquisition Corp (6)
-
Perrigo (15)
-
Petros Pharmaceuticals, Inc. (2)
-
Pfizer (1)
-
Phathom Pharmaceuticals, Inc. (9)
-
PLIANT THERAPEUTICS, INC. (3)
-
Processa Pharmaceuticals, Inc. (2)
-
Pulmatrix, Inc. (1)
-
QUANTA INC (1)
-
Rain Therapeutics Inc. (1)
-
Rani Therapeutics Holdings, Inc. (3)
-
REATA PHARMACEUTICALS INC (1)
-
Recro Pharma, Inc. (1)
-
RELMADA THERAPEUTICS, INC. (5)
-
RespireRx Pharmaceuticals Inc. (8)
-
resTORbio, Inc. (15)
-
Revance Therapeutics, Inc. (5)
-
Roivant Sciences Ltd. (3)
-
Royalty Pharma plc (2)
-
Satsuma Pharmaceuticals, Inc. (7)
-
Scopus BioPharma Inc. (2)
-
SCYNEXIS INC (1)
-
SenesTech, Inc. (2)
-
Sienna Biopharmaceuticals, Inc. (4)
-
Supernus Pharmaceuticals, Inc. (6)
-
Tarsus Pharmaceuticals, Inc. (2)
-
Tenzing Acquisition Corp. (4)
-
Terns Pharmaceuticals, Inc. (8)
-
Terra Tech Corp. (5)
-
TEVA PHARMACEUTICAL INDUSTRIES LTD (4)
-
TFF Pharmaceuticals, Inc. (1)
-
TherapeuticsMD, Inc. (1)
-
Theseus Pharmaceuticals, Inc. (2)
-
TITAN PHARMACEUTICALS INC (1)
-
Trevi Therapeutics, Inc. (4)
-
Tricida, Inc. (1)
-
Trulieve Cannabis Corp. (1)
-
Upjohn Inc (7)
-
Urovant Sciences Ltd. (2)
-
Vallon Pharmaceuticals, Inc. (4)
-
Ventyx Biosciences, Inc. (4)
-
Virpax Pharmaceuticals, Inc. (4)
-
Vitality Biopharma, Inc. (1)
-
Wave Life Sciences Ltd. (5)
-
ZOGENIX, INC. (4)
-
Zynerba Pharmaceuticals, Inc. (1)
Recent Contracts
-
9 Meters Biopharma, Inc. 2022 Stock Incentive Plan
(INNOVATE BIOPHARMACEUTICALS, INC., Filed With SEC on June 22, 2022)
-
Amendment to 2020 Long-Term Incentive Plan
(Liquidia Corp, Filed With SEC on June 17, 2022)
-
Eyenovia, Inc. Amended and Restated 2018 Omnibus Stock Incentive Plan
(EYENOVIA, INC., Filed With SEC on June 17, 2022)
-
Relmada Therapeutics, Inc. 2021 Equity Incentive Plan, as amended
(RELMADA THERAPEUTICS, INC., Filed With SEC on June 1, 2022)
-
Canopy Growth Corporation Amended and Restated Omnibus Incentive Plan
(Canopy Growth Corp, Filed With SEC on May 31, 2022)
-
Form of Award Agreement Awarding Restricted Stock Units under the Novan, Inc. 2016 Incentive Award Plan
(Novan, Inc., Filed With SEC on May 16, 2022)
-
Description of unwritten cash bonus plan adopted June 14, 2021
(Medicine Man Technologies, Inc., Filed With SEC on May 16, 2022)
-
Form of Incentive Stock Option Award under 2021 Plan
(Cingulate Inc., Filed With SEC on May 12, 2022)
-
Forms of Option Grant Notice and Option Agreement under the 2021 Equity Incentive Plan Long-Term Incentive Program
(Panacea Acquisition Corp, Filed With SEC on May 9, 2022)
-
Form of Restricted Stock Unit Agreement under 2018 Stock Incentive Plan
(ARVINAS, INC., Filed With SEC on May 5, 2022)